Suchergebnisse - "Ge, Ke"

PubPharm (58)

11

Effectiveness of parent-training program on children with autism spectrum disorder in China

enthalten in: International journal of developmental disabilities | 2022

von Liang, S. | Zheng, R. | Zhang, L. | +4

12

C-X-C chemokine receptor 2 (Cxcr2) promotes hepatocellular carcinoma immune evasion via regulating programmed death-ligand 1 (PD-L1)

enthalten in: Biological chemistry | 2021

von Wan, Y. | Ge, K. | Zhou, W. | +3

13

EIF3B promotes cancer progression in pancreatic cancer

enthalten in: Scandinavian journal of gastroenterology | 2021

von Zhu, H. | Shan, Y. | Ge, K. | +3

14

Interactional mechanisms of Paenibacillus polymyxa SC2 and pepper (Capsicum annuum L.) suggested by transcriptomics

enthalten in: BMC microbiology | 2021

von Liu, H. | Li, Y. | Ge, K. | +4

15

Interactional mechanisms of Paenibacillus polymyxa SC2 and pepper (Capsicum annuum L.) suggested by transcriptomics

enthalten in: BMC microbiology | 2021

von Liu, H. | Li, Y. | Ge, K. | +4

16

C-X-C chemokine receptor 2 (Cxcr2) promotes hepatocellular carcinoma immune evasion via regulating programmed death-ligand 1 (PD-L1)

enthalten in: Biological chemistry | 2021

von Wan, Y. | Ge, K. | Zhou, W. | +3

17

C-X-C chemokine receptor 2 (Cxcr2) promotes hepatocellular carcinoma immune evasion via regulating programmed death-ligand 1 (PD-L1)

enthalten in: Biological chemistry | 2021

von Wan, Y. | Ge, K. | Zhou, W. | +3

18

Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy

enthalten in: Cellular oncology (Dordrecht) | 2020

von Zhu, H. | Shan, Y. | Ge, K. | +3

19

Nanomedicine-mediated induction of immunogenic cell death and prevention of PD-L1 overexpression for enhanced hepatocellular carcinoma therapy

enthalten in: Cancer nanotechnology | 2020

von Zhu, H. | Zhou, W. | Wan, Y. | +3

20

Nanomedicine-mediated induction of immunogenic cell death and prevention of PD-L1 overexpression for enhanced hepatocellular carcinoma therapy

enthalten in: Cancer nanotechnology | 2020

von Zhu, H. | Zhou, W. | Wan, Y. | +3